Latest News, Local News, International News, US Politics, Economy

Leaders of Pharmaceutical companies condemn FDA approval of abortion pill ruling

The Justice Department formally requested a federal appeals court on Monday to stay an order from a US district court judge that delayed the FDA’s approval of the abortion pill, calling the ruling extraordinary and unprecedented.

The Biden administration is appealing the decision of U.S. District Court Judge Matthew Kacsmaryk and asked the U.S. The Court of Appeals for the Fifth Circuit has ordered that his ruling stay while the case is being heard. 

Giving more time Assess the Appeal

In reaction to Kacsmaryk’s verdict, which barred the FDA’s approval of mifepristone, the Biden administration moved quickly.

The judge, chosen by former President Donald Trump, delayed his decision until Friday to enable the Justice Department time to appeal, and the Justice Department requested that the 5th Circuit reply to its request for a stay by noon on Wednesday.

A separate decision from a federal district judge in Washington, also released Friday, prevents the FDA from changing the status quo regarding the availability of mifepristone in 16 states and the District of Columbia.

These states, as well as D.C. In February, the Biden administration was sued over a set of limits established on the medicine, with the goal of preserving access to it.

The Justice Department has asked the court for clarification on its obligations under the injunction.

Read more: How and why prolonged stress leads to hair loss, heart disease, and other problems

Prominent Doctors’ Statements

Leaders-of-pharmaceutical-companies-condemn-fda-approval-of-abortion-pill-ruling
The Justice Department formally requested a federal appeals court on Monday to stay an order from a U.S. district court judge that delayed the FDA’s approval of the abortion pill, calling the ruling “extraordinary and unprecedented.”

Danco’s filing included affidavits from two famous doctors who have sworn under oath about the safety of mifepristone and warned that if the district court decision is allowed to stand, their patients will be irreparably harmed.

Dr. Courtney Schreiber, a professor in the Department of Obstetrics and Gynecology at the University of Pennsylvania, makes one such statement.

She stated that due to their anatomy, some patients are unable to have a procedural abortion, the second technique of terminating a pregnancy, and that others may have to choose between having a re-traumatizing pelvic exam and procedure or carrying an unwanted pregnancy as a result of rape to term.

Read more: Social Security tax exemption receives an inflation-adjusted update

Leave A Reply

Your email address will not be published.